Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy-Reference-Cited by-同舟云学术

Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy

Published:2003-01 Issue:2 Volume:120 Page:235-242
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Abildgaard Niels,Brixen Kim,Kristensen Jens E.,Eriksen Erik F.,Nielsen Johan L.,Heickendorff Lene

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04050.x/fullpdf

Reference28 articles.

1. Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide, and hyaluronan;Abildgaard;American Journal of Hematology,1994

2. Assessment of bone involvement in patients with multiple myeloma using bone densitometry;Abildgaard;European Journal of Haematology,1996

3. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum;Abildgaard;British Journal of Haematology,1997

4. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma;Abildgaard;European Journal of Haematology,2000

5. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells;Barille;Blood,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive biomarker developments in multiple myeloma;Journal of Hematology & Oncology;2021-09-23

2. Proteomics-inspired precision medicine for treating and understanding multiple myeloma;Expert Review of Precision Medicine and Drug Development;2020-02-24

3. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma;Leukemia & Lymphoma;2018-01-18

4. Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2017-08-24

5. Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers;European Journal of Haematology;2015-12-21